Sun Pharma Q1 Preview: Strong US, domestic sales to aid profit growth but high R&D to drag margins
According to a Moneycontrol poll of 13 brokerages, Sun Pharma's revenue is pegged to grow slightly more than 8 percent to Rs 12,904 crore in the first quarter ...
CNBC Awaaz
1 day ago